Protein Expression Market by Type (Algal-Based Expression Systems, Cell-Free Expression Systems, Insect Cell Expression Systems), Product & Service (Competent Cells, Expression Vectors, Instruments), Application, End-User - Global Forecast 2024-2030

Protein Expression Market by Type (Algal-Based Expression Systems, Cell-Free Expression Systems, Insect Cell Expression Systems), Product & Service (Competent Cells, Expression Vectors, Instruments), Application, End-User - Global Forecast 2024-2030


The Protein Expression Market size was estimated at USD 3.59 billion in 2023 and expected to reach USD 4.09 billion in 2024, at a CAGR 14.12% to reach USD 9.07 billion by 2030.

Global Protein Expression MarketProtein expression is a fundamental biological process wherein the information encoded within a gene is utilized to synthesize proteins. These proteins are essential for various cellular functions, including growth, development, signaling pathways, and metabolic activity. Protein expression involves two primary steps: transcription and translation. During the transcription step, the DNA sequence of a specific gene is copied into messenger RNA (mRNA), serving as a protein synthesis template during the ribosome translation procedure. The study of protein expression has numerous applications in several fields, such as biotechnology, pharmaceuticals, agriculture, and basic research. The primary goal is to express target proteins for research purposes or therapeutic applications in host organisms such as bacteria, yeast, mammalian, and insect cells. The increasing cases of cancer and diabetes necessitate the development of innovative therapies based on protein function understanding. However, high costs associated with advanced technologies for large-scale recombinant protein production and strict regulatory requirements impede market development. Complexities involving protein expression due to toxicity or folding issues may require alternative systems or techniques. In addition, manufacturers invest in R&D to enhance existing expression platforms through process optimization or the development of innovative tools to improve efficiency, reduce costs, and minimize protein production failures. Market players collaborate with research institutions focused on synthetic biology to explore new approaches for customizing biological pathways or biomolecules with potential applications in protein expression.Regional InsightsIn the Americas, strong R&D infrastructure, a high number of biotechnology companies, and increasing government funding for life science research contribute to the growth of the protein expression market. Public funding initiatives, including the National Institutes of Health (NIH), support innovative protein expression technology research projects. In the Asia-Pacific, extensive research activities in the biopharmaceutical industry due to the rising prevalence of chronic diseases and advancements in cell culture technologies have raised the adoption of the protein expression process. In recent years, the APAC region has witnessed rapid expansion in its protein expression market as local and international players invest heavily in research & development (R&D) initiatives and expand their manufacturing capabilities. In the EMEA region, Europe boasts a robust life sciences sector with strong research capabilities fueled by investments from private firms and governments. EU countries have witnessed increased investment in synthetic biology-driven protein expression projects through the Horizon 2020 framework program. The Middle East & Africa region has grown moderately due to limited industrial development activities and financial constraints affecting R&D investment levels. However, collaborative efforts between regional institutions and international organizations help propel advancements in this area through capacity-building programs to boost local expertise in molecular biology techniques.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Protein Expression Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Protein Expression Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Protein Expression Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Agilent Technologies, Inc., Artes Biotechnology GmbH, ARVYS Proteins, Inc., Bio-Rad Laboratories, Inc., Bioneer Corporation, Boster Biological Technology, BPS Bioscience, Inc., Charles River Laboratories International, Inc., Cusabio Technology LLC, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Genscript Biotech Corporation, Jena Bioscience GmbH, Jubilant Pharmova Limited, Leniobio GmbH, Lifesensors Inc., Lonza Group Ltd., Lucigen Corporation, Merck KgaA, New England Biolabs, Inc., Novoprotein Scientific Inc., Oxford Expression Technologies Ltd., Peak Proteins Ltd., Promab Biotechnologies, Inc., Promega Corporation, Proteos, Inc., Qiagen N.V., R&D Systems, Inc., RayBiotech Life, Inc., Sino Biological, Inc., Synbio Technologies, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Protein Expression Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Algal-Based Expression Systems
Cell-Free Expression Systems
Insect Cell Expression Systems
Baculovirus Systems
Mammalian Cell Expression Systems
Chinese Hamster Ovary Systems
Prokaryotic Expression Systems
Escherichia Coli Systems
Yeast Expression Systems
K. Lactis Systems
Pichia Systems
Saccharomyces Systems
Product & Service
Competent Cells
Expression Vectors
Instruments
Reagents
Application
Industrial
Research
Therapeutic
End-User
Academic Research Institutes
Contract Research Organizations & Contract Manufacturing Organizations (CRO & CMO)
Pharmaceutical & Biopharmaceutical Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Protein Expression Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Protein Expression Market?
3. What are the technology trends and regulatory frameworks in the Protein Expression Market?
4. What is the market share of the leading vendors in the Protein Expression Market?
5. Which modes and strategic moves are suitable for entering the Protein Expression Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Protein Expression Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of infectious & chronic diseases among geriatric population and children
5.1.1.2. Rising focus on personalized medicine & protein therapeutics in the consumers
5.1.1.3. Surging inclination of demand toward biologics and biosimilars proteins
5.1.2. Restraints
5.1.2.1. Complex production and contamination risks during the development of protein expression
5.1.3. Opportunities
5.1.3.1. Advancements in synthetic biology and surging investments protein development
5.1.3.2. Growing potential for recombinant protein in animal reproduction, feed
efficiency, and health
5.1.4. Challenges
5.1.4.1. High cost of protein expression reagents & instruments and significant shortage of trained healthcare professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Protein Expression Market, by Type
6.1. Introduction
6.2. Algal-Based Expression Systems
6.3. Cell-Free Expression Systems
6.4. Insect Cell Expression Systems
6.5.1. Baculovirus Systems
6.5. Mammalian Cell Expression Systems
6.6.1. Chinese Hamster Ovary Systems
6.6. Prokaryotic Expression Systems
6.7.1. Escherichia Coli Systems
6.7. Yeast Expression Systems
6.8.1. K. Lactis Systems
6.8.2. Pichia Systems
6.8.3. Saccharomyces Systems
7. Protein Expression Market, by Product & Service
7.1. Introduction
7.2. Competent Cells
7.3. Expression Vectors
7.4. Instruments
7.5. Reagents
8. Protein Expression Market, by Application
8.1. Introduction
8.2. Industrial
8.3. Research
8.4. Therapeutic
9. Protein Expression Market, by End-User
9.1. Introduction
9.2. Academic Research Institutes
9.3. Contract Research Organizations & Contract Manufacturing Organizations (CRO & CMO)
9.4. Pharmaceutical & Biopharmaceutical Companies
10. Americas Protein Expression Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Protein Expression Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Protein Expression Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Polyplus Acquires Xpress Biologics to Expand Plasmid DNA Offer
13.3.2. New Product Launch & Enhancement
13.3.2.1. 10x Genomics Launches Visium CytAssist Gene and Protein Expression Assay
13.3.2.2. Roche Launches PRAME (EPR20330) Antibody to Identify PRAME Protein Expression in Patients that May Have Melanoma
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abcam PLC
14.1.2. Agilent Technologies, Inc.
14.1.3. Artes Biotechnology GmbH
14.1.4. ARVYS Proteins, Inc.
14.1.5. Bio-Rad Laboratories, Inc.
14.1.6. Bioneer Corporation
14.1.7. Boster Biological Technology
14.1.8. BPS Bioscience, Inc.
14.1.9. Charles River Laboratories International, Inc.
14.1.10. Cusabio Technology LLC
14.1.11. Eurofins Scientific SE
14.1.12. F. Hoffmann-La Roche AG
14.1.13. Genscript Biotech Corporation
14.1.14. Jena Bioscience GmbH
14.1.15. Jubilant Pharmova Limited
14.1.16. Leniobio GmbH
14.1.17. Lifesensors Inc.
14.1.18. Lonza Group Ltd.
14.1.19. Lucigen Corporation
14.1.20. Merck KgaA
14.1.21. New England Biolabs, Inc.
14.1.22. Novoprotein Scientific Inc.
14.1.23. Oxford Expression Technologies Ltd.
14.1.24. Peak Proteins Ltd.
14.1.25. Promab Biotechnologies, Inc.
14.1.26. Promega Corporation
14.1.27. Proteos, Inc.
14.1.28. Qiagen N.V.
14.1.29. R&D Systems, Inc.
14.1.30. RayBiotech Life, Inc.
14.1.31. Sino Biological, Inc.
14.1.32. Synbio Technologies
14.1.33. Thermo Fisher Scientific, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. PROTEIN EXPRESSION MARKET RESEARCH PROCESS
FIGURE 2. PROTEIN EXPRESSION MARKET SIZE, 2023 VS 2030
FIGURE 3. PROTEIN EXPRESSION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PROTEIN EXPRESSION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PROTEIN EXPRESSION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PROTEIN EXPRESSION MARKET DYNAMICS
FIGURE 7. PROTEIN EXPRESSION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. PROTEIN EXPRESSION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
FIGURE 10. PROTEIN EXPRESSION MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. PROTEIN EXPRESSION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. PROTEIN EXPRESSION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. PROTEIN EXPRESSION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PROTEIN EXPRESSION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS PROTEIN EXPRESSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES PROTEIN EXPRESSION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PROTEIN EXPRESSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. PROTEIN EXPRESSION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. PROTEIN EXPRESSION MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings